DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Marriott Wardman Park Hotel

2020 年 01 月 27 日 7:00 上午 - 2020 年 01 月 29 日 4:15 下午

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 9: Considerations for Medication Error Pharmacovigilance

Session Chair(s)

Jo  Wyeth, PharmD

Jo Wyeth, PharmD

Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER

FDA, United States

Medication errors have a significant public health burden. This session will discuss the impact of medication errors, current state of medication error pharmacovigilance, and propose directions for building a pharmacovigilance medication error program for the future.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Recognize that medication error prevention requires a collaborative effort among regulators, industry, patients, healthcare providers, and other stakeholders
  • Identify differences and challenges in the approach for medication error pharmacovigilance versus adverse event pharmacovigilance
  • Describe current and emerging approaches for surveilling medication errors

Speaker(s)

Christina  Michalek, RPh

Medication Errors: Impact on the Victims

Christina Michalek, RPh

Institute for Safe Medication Practices , United States

Medication Safety Specialist

Reema  Mehta, PharmD, MPH

Speaker

Reema Mehta, PharmD, MPH

Pfizer Inc, United States

Senior Director, Head of Risk Management and Safety Surveillance Research

Jo  Wyeth, PharmD

Roadmap for Medication Error Pharmacovigilance

Jo Wyeth, PharmD

FDA, United States

Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER

Allan  Fong, MS

Natural Language Processing and Machine Learning with Patient Safety Event Reports

Allan Fong, MS

Medstar Health National Center For Human Factors In Healthcare, United States

Research Scientist and Data Scientist

Lubna  Merchant, PharmD, MS

Panelist

Lubna Merchant, PharmD, MS

Pfizer Inc , United States

Director, Risk Management Center of Excellence

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。